Meeting/Event

Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings

This is Archived Content. This content is available for historical purposes only. It may not reflect the current state of science or language from the National Institute on Drug Abuse (NIDA).
View current meetings on nida.nih.gov.

Details

to
Albuquerque, New Mexico

Contact

NIDA Clinical Trials Network

United States

Meeting Summary

2010 Meeting Overview:

The National Institute on Drug Abuse (NIDA) hosted its 8th Blending Conference in partnership with the University of New Mexico, the University of Arizona, and the University of California, San Francisco on April 22-23, 2010, in Albuquerque, New Mexico.  The Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings Meeting provided an opportunity to promote communication among researchers, treatment providers, and policy makers, while also delivering pioneering research findings to the field.

The two-day conference consisted of four plenary talks and the Eileen Pencer Memorial Lecture by Dr. William Miller.  There were also 25 afternoon breakout sessions led by top experts in the field.

Attendance:

Over 1300 attendees registered for this meeting.  Attendees expressed excitement and gratitude about experiencing NIDA's Blending Conference and written feedback documented that 77% of participants intend to subsequently change their practice as a result of attending this Blending Conference. Eighty-one percent said that the program enhanced their professional effectiveness.

Agendas:

Meeting Day 1

Begin End Session Faculty
7:00 a.m. 9:00 a.m. Registration
9:00 a.m. 9:30 a.m. Introductions and Welcoming Speakers Timothy P. Condon, Ph.D.
9:30 a.m. 11:00 a.m. Opening Plenary Nora D. Volkow, M.D.
11:00 a.m. 12:00 p.m. Break and Poster Session
12:00 p.m. 1:30 p.m. Afternoon Plenary Donald Warne, M.D.
1:30 p.m. 2:00 p.m. Afternoon Breakout Sessions
2:00 p.m. 3:45 p.m. 1. Screening, Brief Intervention and Referral to Treatment: Translating Knowledge to Practice Judith A. Bernstein, R.N.C., M.S.N., Ph.D.
Edward Bernstein, M.D.
2. Out-Patient Buprenorphine Treatment of Prescription Opiate Addiction Roger Weiss, M.D.
Jack McCarthy, M.D.
3. Employment Based Settings Elizabeth Merrick, Ph.D., M.S.W.
Tamara Cagney, R.N., M.F.T., Ed.D.
Eric Goplerud, Ph.D., M.A.
4. Smoking Prevention & Early Intervention Scott Leischow, Ph.D.
Myra Muramoto, M.D., M.P.H.
Raymond Niaura, Ph.D.
5. Fetal Alcohol Spectrum Disorders Phil May, Ph.D.
Wendy Kalberg, M.A., CED
6. Evidence-Based Treatment Interventions for African Americans Kathy Burlew, Ph.D.
Cheryl Grills, Ph.D.
3:45 p.m. 4:00 p.m Break
4:00 p.m. 5:30 p.m. 7. Co-Occurring Disorders Kim T. Mueser, Ph.D.
Joan Zweben, Ph.D.
8. Buprenorphine/Methadone in the Treatment of Adolescents and Young Adults Geetha Subramaniam, M.D.
Shannon Garrett, LGSW, CSC-AD
9. Working with the Family Members of Treatment Refusers: CRAFT Robert J. Meyers, Ph.D.
Jane Ellen Smith, Ph.D.
10. HIV Testing & Counseling Lisa R. Metsch, Ph.D.
Tim M. Matheson, Ph.D.
11. Native American Track Treatment and Recovery: Historical Trauma and Present Day Manifestations Karina Walters, Ph.D.
Alvin Warren
12. Benzodiazepine Use and Misuse in Addiction Treatment Settings Peter Roy-Byrne, M.D.
Patrick Abbott, M.D.
6:30 p.m. 8:00 p.m. Technical Assistance Workshop

Meeting Day 2

Begin End Session Faculty
7:00 a.m. 8:30 a.m. Registration
7:00 a.m. 2:30 p.m. Poster Viewing
8:30 a.m. 8:45 a.m. Opening Remarks
8:45 a.m. 9:45 a.m. Morning Plenary Barbara McCrady, Ph.D.
9:45 a.m. 10:00 a.m. Break
10:00 a.m. 11:00 a.m. Morning Plenary Scott Henggeler, Ph.D.
11:00 a.m. 12:00 p.m. Poster Session
12:00 p.m. 1:30 p.m. NIDA Clinical Trials Network Poster Award
Eileen Pencer Memorial Lecture 		William R. Miller, Ph.D.
1:30 p.m. 2:00 p.m. Afternoon Breakout Sessions
2:00 p.m. 3:45 p.m. 13. Providing Culturally Competent Service to Lesbian, Gay, Bisexual and Transgender Thomas Freese, Ph.D.
JoAnne Keatley, M.S.W.
14. Treatment Through the Criminal Justice System Faye Taxman, Ph.D.
Yvonne Lutter, M.S.W., Psy.D.
15. Veterans Issues and Substance Use Disorders Andy Saxon, M.D.
Peter Banys, M.D., M. Sc.
Susan Storti, PhD., R.N., CARN-AP
16. Addiction-Related Self-Help/Mutual-Aid Groups Lee Ann Kaskutas, Ph.D.
J. Scott Tonigan, Ph.D.
Michael Bogenschutz, M.D.
*17. Native American Track Treatment and Recovery: Adapting Interventions Kamilla Venner, Ph.D.
Ed Parsells
Frank Zavadil
18. Adolescent Drug/Smoking Prevention in Primary and Secondary Schools Anthony Biglan, Ph.D.
Dalene Dutton
19. Promising New Treatments Including Vaccines Thomas R. Kosten, M.D.
Raafat Fahim, Ph.D.
Claire Wilcox, M.D.
3:45 p.m. 4:00 p.m Break
4:00 p.m. 5:30 p.m. 20. Substance Use Among High Risk Adolescents: Related Risks and Treatment Challenges Angela Bryan, Ph.D.
Jerald Belitz, Ph.D.
21. Identification of and Treatment for Prenatal Substance Use: From Research to Practice William F. Rayburn, M.D.
Dace Svikis, Ph.D.
22. Rural Treatment and Telehealth John Roll, Ph.D.
Sanjeev Aurora, M.D., FACP
23. Southwestern Hispanic Concerns in Drug Abuse Andrea Romero, Ph.D.
Felipe Castro, Ph.D.
24. Native American Track Recovery Among AI/AN - Adapting Interventions Ray Daw, M.A.
Dennis Donovan, Ph.D.
Laura Price
Albie Lawrence
25. Drug Courts Today and the Promise for Tomorrow Doug Marlowe, J.D., Ph.D.
Marie Baca, J.D.